Harmony Infra Ventures Bets ₹800 Crore on Luxury Housing Surge in Ghaziabad
Source: Economictimes
Arth Insight · What this means for your wallet
- This project sets a new benchmark for property values in Ghaziabad and nearby NCR, potentially increasing the value of any real estate you already own in these regions.
- The focus on luxury housing could mean fewer new affordable or mid-range housing options, potentially making it more expensive to buy property in areas like Ghaziabad if you're not targeting the high-end segment.
- For potential real estate investors, this trend suggests evolving opportunities (and higher entry costs) in emerging luxury pockets within the NCR.
Real estate developer Harmony Infra Ventures is investing ₹800 crore to develop 'The Horizon Residences,' a premium housing project in Indirapuram. With units priced up to ₹7.5 crore, the project highlights a growing appetite for luxury living in the Delhi-NCR region.
- ▸Harmony Infra Ventures is investing ₹800 crore in a luxury project in Indirapuram, Ghaziabad.
- ▸Individual units are priced at a premium range of ₹6 crore to ₹7.5 crore.
- ▸Strong demand is evident with nearly 40% of the inventory sold shortly after launch.
- ▸The developer projects a total revenue of ₹1,600 crore by the time the project is completed in 2030.
- ✓Harmony Infra Ventures is investing ₹800 crore in a luxury project in Indirapuram, Ghaziabad.
- ✓Individual units are priced at a premium range of ₹6 crore to ₹7.5 crore.
- ✓Strong demand is evident with nearly 40% of the inventory sold shortly after launch.
- ✓The developer projects a total revenue of ₹1,600 crore by the time the project is completed in 2030.
The real estate landscape in the Delhi-NCR region is witnessing a significant shift as luxury housing moves beyond traditional hubs like Gurugram and South Delhi. Harmony Infra Ventures has announced a major investment of ₹800 crore to develop 'The Horizon Residences,' an upscale residential project located in Indirapuram, Ghaziabad.
High Stakes in Indirapuram
The project represents a bold move into the high-ticket segment for the area, featuring a limited collection of 264 luxury units. Reflecting the premium nature of the development, price points are set between ₹6 crore and ₹7.5 crore per unit. Despite these high price tags, early market response has been robust, with approximately 100 units—nearly 38% of the total inventory—already sold out.
This rapid absorption of high-value units signals a fundamental change in buyer behavior in Ghaziabad. Historically known for affordable and mid-segment housing, Indirapuram is now emerging as a preferred destination for affluent investors and end-users seeking premium amenities and exclusivity.
Financial Outlook and Timelines
Harmony Infra Ventures expects the project to generate a total revenue of ₹1,600 crore, effectively doubling its initial investment. The developer has set a completion deadline for the year 2030, aligning with the long-term infrastructure growth projected for the NCR region.
- Investment: ₹800 crore
- Expected Revenue: ₹1,600 crore
- Total Units: 264 luxury residences
- Completion Goal: 2030
A Shift in NCR Real Estate Dynamics
The success of early sales at The Horizon Residences underscores a broader trend across the National Capital Region. As land prices rise and infrastructure improves, developers are increasingly focusing on the "luxury" and "ultra-luxury" categories. Buyers are showing a willingness to pay a premium for larger floor plans, better security, and modern lifestyle facilities, even in areas previously considered secondary markets.
For retail investors and homebuyers, this development serves as a marker for the rising valuation of property in the eastern fringes of the NCR. As the project progresses toward its 2030 completion date, it is expected to set a new benchmark for residential pricing in the Ghaziabad-Noida belt.
Real estate investments carry inherent risks; readers are advised to verify RERA credentials and project details independently before making any financial commitments.
Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.
Frequently Asked Questions
Where is the new luxury project located?
The project, named The Horizon Residences, is located in the Indirapuram area of Ghaziabad within the Delhi-NCR region.
What is the starting price for a home in this project?
Prices for the luxury units in this development start at ₹6 crore and go up to ₹7.5 crore.
When will the construction be completed?
Harmony Infra Ventures expects to complete the project and hand over possession by the year 2030.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about real-estate
BreakingPiramal Pharma Slashes China Reliance to Under 10% for Supply Chain Resilience
Piramal Pharma has significantly reduced its dependence on Chinese raw materials to less than 10%. This strategic move aims to enhance supply chain resilience against geopolitical risks, with the company expanding its manufacturing footprint to India, the UK, and the US.
Dr Reddy's Pivots to Generic Semaglutide, Biosimilars for Future Growth
Dr Reddy's Laboratories is strategically focusing on the relaunch of generic semaglutide and expanding its biosimilars portfolio to drive future growth. This comes as the company navigates mixed results, with domestic formulations business growing but North American Revlimid sales declining in the September quarter.
Aayush Wellness Launches Calcium & Vitamin D Tablets, Enters ₹1.35 Lakh Crore Bone Health Market
Aayush Wellness Limited has launched new calcium and vitamin D tablets, marking its entry into India's significant bone and joint health segment. This expansion reflects the growing consumer demand for preventive healthcare and nutritional supplements designed to support musculoskeletal health.
Related Stories
BreakingPiramal Pharma Slashes China Reliance to Under 10% for Supply Chain Resilience
Piramal Pharma has significantly reduced its dependence on Chinese raw materials to less than 10%. This strategic move aims to enhance supply chain resilience against geopolitical risks, with the company expanding its manufacturing footprint to India, the UK, and the US.
Dr Reddy's Pivots to Generic Semaglutide, Biosimilars for Future Growth
Dr Reddy's Laboratories is strategically focusing on the relaunch of generic semaglutide and expanding its biosimilars portfolio to drive future growth. This comes as the company navigates mixed results, with domestic formulations business growing but North American Revlimid sales declining in the September quarter.
Aayush Wellness Launches Calcium & Vitamin D Tablets, Enters ₹1.35 Lakh Crore Bone Health Market
Aayush Wellness Limited has launched new calcium and vitamin D tablets, marking its entry into India's significant bone and joint health segment. This expansion reflects the growing consumer demand for preventive healthcare and nutritional supplements designed to support musculoskeletal health.
NITI Aayog Eyes Policy Reforms to Boost India's Medical Device Manufacturing
NITI Aayog is actively exploring new policy measures to enhance India's domestic manufacturing capabilities for medical and dental devices. The initiative addresses significant hurdles like complex regulations and cost disadvantages faced by local producers. The goal is to strengthen the 'Make in India' drive within the crucial healthcare sector.